Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO) resulting from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback